Exercise Prescription for the Improvement of Quality of Life in Elderly Patients With Multiple Myeloma
NCT04100044 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9
Last updated 2025-04-29
Summary
This trial studies how well exercise prescription works in improving quality of life in elderly patients with multiple myeloma. Engaging and adhering to an exercise program may improve functional status and quality of life and decrease pain and skeletal-related events. This study is being done to see if elderly patients with multiple myeloma can participate in a physical activity program.
Conditions
- Plasma Cell Myeloma
Interventions
- OTHER
-
Exercise Counseling
Meet with physical therapist
- BEHAVIORAL
-
Exercise Intervention
Receive personalized home exercise intervention
- OTHER
-
Questionnaire administration
Ancillary studies
- OTHER
-
Quality-of-Life Assessment
Ancillary studies
Sponsors & Collaborators
-
Thomas Jefferson University
lead OTHER
Principal Investigators
-
Adam Binder, MD · Sidney Kimmel Cancer Center at Thomas Jefferson University
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-24
- Primary Completion
- 2022-05-27
- Completion
- 2022-05-27
Countries
- United States
Study Locations
More Related Trials
-
The Myeloma Pack: A Multi-Modality Educational Intervention Strategy to Engage Patients With Multiple Myeloma
NCT03777306 ·Status: COMPLETED ·Phase: NA
-
Autologous Transplant for Multiple Myeloma
NCT00177047 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Patient and Care Partner Experiences Living With Multiple Myeloma (PaCE-MM)
NCT05276622 ·Status: TERMINATED
-
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
NCT03127761 ·Status: RECRUITING
-
Geriatric Assessments in Senior Adults With Multiple Myeloma
NCT01746030 ·Status: COMPLETED
-
Personalized Autologous Transplant for Multiple Myeloma
NCT04483206 ·Status: RECRUITING ·Phase: PHASE1
-
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
NCT05136807 ·Status: RECRUITING
-
Microtransplantation Versus Auto-SCT in ≥PR Multiple Myeloma Patients
NCT02981199 ·Status: UNKNOWN ·Phase: NA
-
Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma
NCT00002653 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Early Palliative Care Integration on Patients With Newly Diagnosed Multiple Myeloma
NCT04248244 ·Status: COMPLETED ·Phase: NA
-
Assessing the Impact of a Financial Navigation Program for Patients With Multiple Myeloma
NCT05448196 ·Status: COMPLETED ·Phase: NA
-
Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma
NCT05673083 ·Status: ACTIVE_NOT_RECRUITING
-
Back Pain Prevention in Multiple Myeloma Using an External Spinal Brace
NCT02898064 ·Status: COMPLETED ·Phase: NA
-
Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma
NCT00036140 ·Status: COMPLETED ·Phase: PHASE1
-
Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma
NCT01849783 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma
NCT06149910 ·Status: RECRUITING
-
Etiology of Multiple Myeloma: A Case-Control Study
NCT00505999 ·Status: UNKNOWN
-
Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma
NCT01142232 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Dietary Study for People With Multiple Myeloma
NCT07226609 ·Status: RECRUITING ·Phase: NA
-
Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation
NCT01660633 ·Status: COMPLETED ·Phase: PHASE2
-
Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I
NCT00171925 ·Status: TERMINATED ·Phase: PHASE3
-
Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma
NCT01234129 ·Status: COMPLETED
-
Helical Tomotherapy in Multiple Myeloma
NCT05970198 ·Status: RECRUITING ·Phase: NA
-
Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma
NCT00416208 ·Status: COMPLETED ·Phase: PHASE3
-
S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
NCT00900263 ·Status: COMPLETED